Psoriasis is estimated to affect about 2-4% of the population in western countries1. Psoriasis is associated with an increased risk of cardiovascular events, metabolic diseases, including diabetes and psychological disorders, such as depression.2
Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM, and the Identification and Management of Psoriasis and Associated Comorbidi Ty (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.
Flatz L, Conrad C. Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy. Psoriasis Targets Ther2013;1–10.